home / stock / allo / allo short
Short Information | Allogene Therapeutics Inc. (NASDAQ:ALLO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 5,421,510 |
Total Actual Volume | 33,321,393 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 271,076 |
Average Short Percentage | 16.01% |
Is there a ALLO Short Squeeze or Breakout about to happen?
See the ALLO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-23-2024 | $3.41 | $3.37 | $3.53 | $3.36 | 1,606,756 | 205,310 | 12.78% |
04-22-2024 | $3.49 | $3.4 | $3.63 | $3.38 | 1,789,993 | 297,471 | 16.62% |
04-19-2024 | $3.45 | $3.47 | $3.555 | $3.38 | 2,013,218 | 369,549 | 18.36% |
04-18-2024 | $3.52 | $3.46 | $3.56 | $3.45 | 1,245,819 | 170,074 | 13.65% |
04-17-2024 | $3.57 | $3.51 | $3.58 | $3.455 | 2,507,828 | 199,086 | 7.94% |
04-16-2024 | $3.5 | $3.5 | $3.555 | $3.395 | 1,388,064 | 274,125 | 19.75% |
04-15-2024 | $3.86 | $3.55 | $3.88 | $3.535 | 1,592,742 | 353,595 | 22.2% |
04-12-2024 | $3.98 | $3.8 | $4.0062 | $3.74 | 2,882,301 | 432,632 | 15.01% |
04-11-2024 | $4.14 | $3.99 | $4.21 | $3.99 | 2,153,258 | 416,034 | 19.32% |
04-10-2024 | $3.91 | $4.07 | $4.25 | $3.87 | 2,326,913 | 712,081 | 30.6% |
04-09-2024 | $3.99 | $4.11 | $4.11 | $3.93 | 1,368,742 | 223,265 | 16.31% |
04-08-2024 | $3.96 | $3.98 | $4.04 | $3.895 | 1,129,476 | 143,160 | 12.67% |
04-05-2024 | $4.02 | $3.96 | $4.06 | $3.91 | 939,016 | 134,414 | 14.31% |
04-04-2024 | $4.13 | $4.05 | $4.3 | $4.03 | 1,683,614 | 272,981 | 16.21% |
04-03-2024 | $4.04 | $4.09 | $4.105 | $3.95 | 1,302,318 | 126,696 | 9.73% |
04-02-2024 | $4.26 | $4.07 | $4.26 | $4.06 | 1,544,522 | 261,021 | 16.9% |
04-01-2024 | $4.43 | $4.38 | $4.45 | $4.285 | 1,290,451 | 197,961 | 15.34% |
03-28-2024 | $4.41 | $4.47 | $4.575 | $4.41 | 1,377,673 | 221,633 | 16.09% |
03-27-2024 | $4.28 | $4.46 | $4.63 | $4.14 | 1,897,214 | 225,693 | 11.9% |
03-26-2024 | $4.35 | $4.21 | $4.475 | $4.21 | 1,281,475 | 184,729 | 14.42% |
News, Short Squeeze, Breakout and More Instantly...
Allogene Therapeutics Inc. Company Name:
ALLO Stock Symbol:
NASDAQ Market:
Allogene Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology compan...
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will participat...
Cema-cel Pivotal ALPHA3 First Line (1L) Consolidation Trial in Large B-Cell Lymphoma (LBCL) : Start-Up Activities Underway; Enrollment to Begin Mid-2024 Cema-cel Phase 1 ALPHA2 Trial in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): Enrolling Patients with Initial Dat...